SynthesisClinical cancer research : an official journal of the American Association for Cancer Research2024

ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis.

Víctor A Arrieta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.